Skip to main content

Table 4 Analysis of hospital outcomes by myosteatosis

From: The impact of sarcopenia and myosteatosis on postoperative outcomes in patients with inflammatory bowel disease

 

All patients (n = 77)

n (%)

No myosteatosis (n = 51)

n (%)

Myosteatosis (n = 26)

n (%)

p-value

Major complication (Clavien-Dindo ≥ 3a)

16 (21)

9 (18)

7 (27)

0.254a

Major intra-abdominal leak

11 (14)

5 (10)

6 (23)

0.111a

Length of hospital admission, days (median, IQR)

10 (8–15)

10 (7–13)

13 (9–24)

0.039b

Hospital readmission < 30 days

10 (13)

3 (6)

7 (27)

0.011c

  1. IQR interquartile range
  2. a χ2 test, b Mann-Whitney U test, c Fischer’s exact test